Vaccine delivery devices market seen reaching $10.9 billion by 2030

The vaccine delivery devices market is projected to rise from $7.01 billion in 2025 to $10.9 billion by 2030, driven by broader immunization programs, infectious disease pressure and demand for safer, more precise vaccine administration. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Vaccine delivery devices are becoming more central to public health as countries push for faster, safer and more precise immunization. - Rising infectious disease cases and pandemic preparedness spending are increasing demand for better vaccine administration tools. - The market outlook points to continued adoption of technologies that could improve patient comfort, self-administration and dosing accuracy.

What happened: - The Business Research Company said the global vaccine delivery devices market is projected to grow from $7.01 billion in 2025 to $7.72 billion in 2026. - The market is forecast to reach $10.9 billion by 2030. - The company published the outlook on Sept. 2, 2026, from London. - The report also includes a free sample and full market report links: Download a free sample and View the full report.

The details: - The market’s 2025-2026 growth rate is estimated at 10.1%. - The report ties historic growth to broader national immunization programs, higher global vaccine production, more infectious disease cases, improvements in cold-chain logistics and continued use of syringe-based delivery. - Future growth is linked to next-generation vaccines, self-administration devices, pandemic preparedness, investment in vaccine-access technologies, and a greater focus on dosage precision and patient adherence. - Emerging trends include needle-free injection technologies, microneedle patch systems, alternative vaccine delivery routes, mass immunization efforts and a stronger emphasis on safety and comfort. - Vaccine delivery devices are specialized tools or systems designed to administer vaccines safely and precisely while minimizing patient discomfort. - These devices help support vaccine distribution and administration for disease prevention and community immunity. - Rising infectious diseases remain a major driver of demand. - The World Health Organization reported about 10.3 million measles cases globally in 2023, a 20% increase from the prior year. - The report says urbanization, international travel, climate change and population density are helping speed pathogen transmission. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to grow fastest during the forecast period. - The analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market forecast suggests vaccine delivery is shifting from a basic supply-chain function to a technology category with room for product differentiation. - The emphasis on self-administration, needle-free systems and microneedle patches points to demand for easier deployment outside traditional clinical settings. - The regional split signals a mature North American market and a faster-expanding opportunity in Asia-Pacific.

What's next: - The Business Research Company expects the market to keep expanding through 2030 as vaccine design and delivery technology evolve. - Watch for more investment in devices that improve access, comfort and precision as immunization programs scale. - The company’s report update adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables.

The bottom line: - Vaccine delivery devices are on track for steady double-digit growth in the near term and a $10.9 billion market by 2030, fueled by public health demand and next-generation administration technologies.